Pancreatic Cancer Research

ResearcherLinköping UniversityActive in the last 2 years

Jens Martin Werner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7156-4370; OpenAlex author ID A5015028238. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
56
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 9

  1. ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Pa… Co-author DOI 10.1245/s10434-024-16021-1↗
  2. Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison … Co-author DOI 10.1007/s00432-022-04112-z↗
  3. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives. Co-author DOI 10.3389/fonc.2020.621937↗
  4. Repurposed Drugs in Pancreatic Ductal Adenocarcinoma: An Update. Co-author DOI 10.1097/ppo.0000000000000372↗
  5. MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells. Co-author DOI 10.1159/000485276↗
  6. Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma. Co-author DOI 10.1038/bjc.2015.72↗
  7. Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-2972↗
  8. Growth inhibition of pancreatic cancer by experimental treatment with 4-phenylbutyrate is associated with increased expression of Connexin 43. Last author DOI 10.3727/096504012x13477145152959↗
  9. [Management of pancreatic cancer: recent advances]. Co-author DOI 10.1055/s-0031-1286107↗

Closest collaborators

The 25 strongest of 56 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alexandr V. Bazhin · 3 shared papers, 2015–2020 · strength 0.27
  2. Christoph Benedikt Westphalen · 2 shared papers, 2019–2023 · strength 0.25
  3. Jan Goesta D’Haese · 2 shared papers, 2019–2020 · strength 0.24
  4. Matthew H. G. Katz · 1 shared paper, 2024 · strength 0.15
  5. Bodil Andersson · 1 shared paper, 2024 · strength 0.15
  6. Karin U. Johansen · 1 shared paper, 2024 · strength 0.15
  7. Tobias Keck · 1 shared paper, 2024 · strength 0.15
  8. Michael B. Ghadimi · 1 shared paper, 2024 · strength 0.15
  9. Bergþór Björnsson · 1 shared paper, 2024 · strength 0.15
  10. Simone Augustinus · 1 shared paper, 2024 · strength 0.15
  11. Izaak Quintus Molenaar · 1 shared paper, 2024 · strength 0.15
  12. Michael Garrett House · 1 shared paper, 2024 · strength 0.15
  13. Susan van Dieren · 1 shared paper, 2024 · strength 0.15
  14. Tara M. Mackay · 1 shared paper, 2024 · strength 0.15
  15. Bobby Tingstedt · 1 shared paper, 2024 · strength 0.15
  16. Waldemar H. Uhl · 1 shared paper, 2024 · strength 0.15
  17. Ulrich Friedrich Wellner · 1 shared paper, 2024 · strength 0.15
  18. Poya Ghorbani · 1 shared paper, 2024 · strength 0.15
  19. Thomas F. Stoop · 1 shared paper, 2024 · strength 0.15
  20. Roeland F. de Wilde · 1 shared paper, 2024 · strength 0.15
  21. Henry Anthony Pitt · 1 shared paper, 2024 · strength 0.15
  22. Christopher Lee Wolfgang · 1 shared paper, 2024 · strength 0.15
  23. Marc G. Besselink · 1 shared paper, 2024 · strength 0.15
  24. Marco Del Chiaro · 1 shared paper, 2024 · strength 0.15
  25. J. Sven D. Mieog · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.